Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$47.98 - $62.75 $815,660 - $1.07 Million
-17,000 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$49.85 - $96.11 $299,100 - $576,660
6,000 Added 54.55%
17,000 $1.06 Million
Q4 2021

Feb 14, 2022

BUY
$77.3 - $105.0 $850,300 - $1.16 Million
11,000 New
11,000 $1.11 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $557M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Permian Investment Partners, LP Portfolio

Follow Permian Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Permian Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Permian Investment Partners, LP with notifications on news.